Federated Hermes, Inc. 13D and 13G filings for Seres Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-07 12:57 pm Sale | 2023-10-31 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 5,175,805 4.040% | -6,324,715 (-55.00%) | Filing |
| 2023-05-10 10:16 am Sale | 2023-04-30 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 11,500,520 9.000% | -6,585,418 (-36.41%) | Filing |
| 2023-02-01 12:15 pm Purchase | 2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 18,085,938 14.520% | 103,682 (+0.58%) | Filing |
| 2022-07-11 2:13 pm Purchase | 2022-06-30 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 17,982,256 14.500% | 11,068,120 (+160.08%) | Filing |
| 2022-02-14 1:46 pm Purchase | 2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 6,914,136 7.530% | 6,914,136 (New Position) | Filing |